{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T17:57:00Z","timestamp":1790272620146,"version":"4.1.0"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2011,1,21]],"date-time":"2011-01-21T00:00:00Z","timestamp":1295568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100001861","name":"Swedish Council for Working Life and Social Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001861","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,2,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background.<\/jats:title><jats:p>A recent rise in the incidence of prostate cancer and a more favorable outcome have increased the proportions of other causes of death in affected men. Extending the survival of prostate cancer patients thus requires knowledge of all causes of death.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>Data on the population, cancers, and causes of death were gathered from the nationwide Swedish Family-Cancer Database. A Cox regression model, comparing prostate cancer patients with all other men, was applied. Hazard ratios (HR) were calculated both for the underlying cause and for dying with a specific cause listed among multiple causes of death.<\/jats:p><\/jats:sec><jats:sec><jats:title>Findings.<\/jats:title><jats:p>Among 686,500 observed deaths, 62,500 were prostate cancer patients. For underlying causes other than prostate cancer, the highest cause-specific HRs were found for external causes (HR, 1.24; 95% confidence interval [CI], 1.16\u20131.31), diseases of the pulmonary circulation (HR, 1.22; 95% CI, 1.09\u20131.37), and heart failure (HR, 1.18; 95% CI, 1.11\u20131.24). For specific multiple causes, the highest HRs were found for anemia (HR, 2.28; 95% CI, 2.14\u20132.42), diseases of the pulmonary circulation (HR, 1.61; 95% CI, 1.55\u20131.68), and urinary system disease (HR, 1.90; 95% CI, 1.84\u20131.96).<\/jats:p><\/jats:sec><jats:sec><jats:title>Interpretations.<\/jats:title><jats:p>Prostate cancer patients have a higher risk for dying from various causes other than prostate cancer, including external causes and heart failure. Mechanisms have been proposed linking these elevated risks to both cancer and treatment. More attention should be paid to comorbidities in men with prostate cancer. The present study fulfills a gap in the knowledge of death causes in prostate cancer patients.<\/jats:p><\/jats:sec>","DOI":"10.1634\/theoncologist.2010-0338","type":"journal-article","created":{"date-parts":[[2011,1,22]],"date-time":"2011-01-22T03:28:19Z","timestamp":1295666899000},"page":"175-181","source":"Crossref","is-referenced-by-count":82,"title":["What Do Prostate Cancer Patients Die Of?"],"prefix":"10.1093","volume":"16","author":[{"given":"Matias","family":"Riihim\u00e4ki","sequence":"first","affiliation":[{"name":"a Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany;"},{"name":"b Center for Primary Care Research, Lund University, Malm\u00f6, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hauke","family":"Thomsen","sequence":"additional","affiliation":[{"name":"a Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Brandt","sequence":"additional","affiliation":[{"name":"a Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Sundquist","sequence":"additional","affiliation":[{"name":"b Center for Primary Care Research, Lund University, Malm\u00f6, Sweden;"},{"name":"c Stanford Prevention Research Center, Stanford University School of Medicine, Stanford, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Hemminki","sequence":"additional","affiliation":[{"name":"a Division of Molecular Genetic Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany;"},{"name":"b Center for Primary Care Research, Lund University, Malm\u00f6, Sweden;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2011,1,21]]},"reference":[{"key":"2021122303223536200_B1","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1002\/(SICI)1097-0142(19980915)83:6<1180::AID-CNCR18>3.0.CO;2-1","article-title":"Cause of death in men diagnosed with prostate carcinoma","volume":"83","author":"Satariano","year":"1998","journal-title":"Cancer"},{"key":"2021122303223536200_B2","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1093\/jnci\/djm249","article-title":"Interpreting trends in prostate cancer incidence and mortality in the five Nordic countries","volume":"99","author":"Kv\u00e5le","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"2021122303223536200_B3","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/ijc.20568","article-title":"Prostate cancer screening, changing age-specific incidence trends and implications on familial risk","volume":"113","author":"Hemminki","year":"2005","journal-title":"Int J Cancer"},{"key":"2021122303223536200_B4","doi-asserted-by":"crossref","first-page":"e1000197","DOI":"10.1371\/journal.pmed.1000197","article-title":"Immediate risk for cardiovascular events and suicide following a prostate cancer diagnosis: Prospective cohort study","volume":"6","author":"Fall","year":"2009","journal-title":"PLoS Med"},{"key":"2021122303223536200_B5","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.eururo.2009.10.035","article-title":"Suicide risk in men with prostate-specific antigen\u2013detected early prostate cancer: A nationwide population-based cohort study from PCBaSe Sweden","volume":"57","author":"Bill-Axelson","year":"2010","journal-title":"Eur Urol"},{"key":"2021122303223536200_B6","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1532-5415.2008.02091.x","article-title":"Cause of death in older men after the diagnosis of prostate cancer","volume":"57","author":"Ketchandij","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"2021122303223536200_B7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/jnci\/92.8.613","article-title":"Causes of death in elderly prostate cancer patients and in a comparison nonprostate cancer cohort","volume":"92","author":"Newschaffer","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"2021122303223536200_B8","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1002\/ijc.24795","article-title":"The Swedish Family-Cancer Database 2009: Prospects for histology-specific and immigrant studies","volume":"126","author":"Hemminki","year":"2010","journal-title":"Int J Cancer"},{"key":"2021122303223536200_B9","article-title":"International Statistical Classification of Diseases and Related Health Problems","volume-title":"Tenth Revision","author":"World Health Organisation","edition":"Second Edition"},{"key":"2021122303223536200_B10","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1468-1331.2008.02503.x","article-title":"Cause of death in patients with dementia disorders","volume":"16","author":"Brunnstr\u00f6m","year":"2009","journal-title":"Eur J Neurol"},{"key":"2021122303223536200_B11","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/01.ede.0000187177.96138.c6","article-title":"A comparison of underlying cause and multiple causes of death: US vital statistics, 2000\u20132001","volume":"17","author":"Redelings","year":"2006","journal-title":"Epidemiology"},{"key":"2021122303223536200_B12","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/ije\/29.3.495","article-title":"Comparing Swedish hospital discharge records with death certificates: Implications for mortality statistics","volume":"29","author":"Johansson","year":"2000","journal-title":"Int J Epidemiol"},{"key":"2021122303223536200_B13","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1080\/00365590802078583","article-title":"Reliability of death certificates in prostate cancer patients","volume":"42","author":"Fall","year":"2008","journal-title":"Scand J Urol Nephrol"},{"key":"2021122303223536200_B14","article-title":"Var D\u00f6r de \u00e4ldre\u2014p\u00e5 Sjukhus, S\u00e4rskilt Boende Eller Hemma? - En Registerstudie. [Where Do Elderly People Die\u2014In a Hospital, Care Home, or Home?\u2014A Registry Study]","volume-title":"In Swedish","author":"Socialstyrelsen [Swedish National Board of Health and Welfare]"},{"key":"2021122303223536200_B15","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.1200\/JCO.2006.06.2497","article-title":"Diabetes and cardiovascular disease during androgen deprivation therapy for prostate cancer","volume":"24","author":"Keating","year":"2006","journal-title":"J Clin Oncol"},{"key":"2021122303223536200_B16","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/jcem.87.2.8299","article-title":"Changes in body composition during androgen deprivation therapy for prostate cancer","volume":"87","author":"Smith","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122303223536200_B17","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1210\/jc.2007-2595","article-title":"Androgen deprivation therapy in prostate cancer and metabolic risk for atherosclerosis","volume":"93","author":"Shahani","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"2021122303223536200_B18","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1046\/j.1365-2265.2002.01551.x","article-title":"Long-term effects of androgen deprivation therapy in prostate cancer patients","volume":"56","author":"Basaria","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"suppl 2","key":"2021122303223536200_B19","doi-asserted-by":"crossref","first-page":"S389","DOI":"10.1007\/s11606-009-0968-y","article-title":"Prostate cancer survivorship: Prevention and treatment of the adverse effects of androgen deprivation therapy","volume":"24","author":"Saylor","year":"2009","journal-title":"J Gen Intern Med"},{"key":"2021122303223536200_B20","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1001\/archinte.166.13.1380","article-title":"Low testosterone levels and the risk of anemia in older men and women","volume":"166","author":"Ferrucci","year":"2006","journal-title":"Arch Intern Med"},{"key":"2021122303223536200_B21","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: Causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"2021122303223536200_B22","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S1470-2045(10)70038-3","article-title":"Risk of thromboembolic diseases in men with prostate cancer: Results from the population-based PCBaSe Sweden","volume":"11","author":"Van Hemelrijck","year":"2010","journal-title":"Lancet Oncol"},{"key":"2021122303223536200_B23","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1538-7836.2009.03275.x","article-title":"Incidence, risk profile and morphological pattern of venous thromboembolism after prostate cancer surgery","volume":"7","author":"Beyer","year":"2009","journal-title":"J Thromb Haemost"},{"issue":"suppl 1","key":"2021122303223536200_B24","first-page":"I9","article-title":"Risk factors for venous thromboembolism","volume":"107","author":"Anderson","year":"2003","journal-title":"Circulation"},{"key":"2021122303223536200_B25","doi-asserted-by":"crossref","first-page":"4881","DOI":"10.1200\/JCO.2009.23.2009","article-title":"Prevention of venous thromboembolism in the cancer surgical patient","volume":"27","author":"Kakkar","year":"2009","journal-title":"J Clin Oncol"},{"key":"2021122303223536200_B26","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1136\/bmj.308.6933.891","article-title":"Deep venous thrombosis and occult malignancy: An epidemiological study","volume":"308","author":"Nordstr\u00f6m","year":"1994","journal-title":"BMJ"},{"key":"2021122303223536200_B27","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood-2006-10-053736","article-title":"Trousseau's syndrome: Multiple definitions and multiple mechanisms","volume":"110","author":"Varki","year":"2007","journal-title":"Blood"},{"key":"2021122303223536200_B28","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(99)06154-1","article-title":"Cancer in patients on dialysis for end-stage renal disease: An international collaborative study","volume":"354","author":"Maisonneuve","year":"1999","journal-title":"Lancet"},{"key":"2021122303223536200_B29","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.2215\/CJN.00310107","article-title":"Comparison of stage at diagnosis of cancer in patients who are on dialysis versus the general population","volume":"2","author":"Taneja","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"2021122303223536200_B30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1159\/000167834","article-title":"Nosocomial bacteriuria in patients with indwelling catheter after radical retropubic prostatectomy for prostate cancer","volume":"81","author":"Bartsch","year":"2008","journal-title":"Urol Int"},{"key":"2021122303223536200_B31","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1097\/01.ju.0000059281.67667.97","article-title":"Fracture risk following bilateral orchiectomy","volume":"169","author":"Melton","year":"2003","journal-title":"J Urol"},{"key":"2021122303223536200_B32","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1210\/jc.2004-1717","article-title":"Aromatase activity and bone homeostasis in men","volume":"89","author":"Gennari","year":"2004","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2010-0338","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2010-0338","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/16\/2\/175\/41852950\/oncolo_16_2_175.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/16\/2\/175\/41852950\/oncolo_16_2_175.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T10:10:24Z","timestamp":1712139024000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/16\/2\/175\/6400695"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,21]]},"references-count":32,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2011,1,21]]},"published-print":{"date-parts":[[2011,2,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2010-0338","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2011,2,1]]},"published":{"date-parts":[[2011,1,21]]}}}